TABLE 1.

Specific Clinical Questions Guiding the AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease (1)

The following questions form the basis of the 87 recommendations included in the AACE/ACE clinical practice guidelines: 1. What are risk factors for ASCVD? 2. What risk categories does AACE/ACE recommend? 3. How is risk assessed? 4. How does type 1 diabetes affect risk? 5. Who should be screened for ASCVD risk and when? 6. What are secondary causes of dyslipidemia? 7. Which screening tests should be used? 8. What are lipid treatment goals? 9 What treatments are available for dyslipidemia? 10. What special considerations should be given to women? 11. What special considerations should be given to children and adolescents? 12. How does treatment of dyslipidemia affect ASCVD risk? 13. How are different drug categories used to treat dyslipidemia? 14. How should treatment be monitored? 15. Is the treatment of dyslipidemia and prevention of ASCVD cost-effective?